跳至主要内容
临床试验/ISRCTN71104460
ISRCTN71104460
已完成
不适用

PRoximal Embolic Protection in Acute myocardial infarction and Resolution of ST-Elevation-combined embolic protection and thrombectomy during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomised comparison using the PROXIS™ device

Academic Medical Centre (AMC) (Netherlands)0 个研究点目标入组 280 人2007年3月5日

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
Myocardial infarction
发起方
Academic Medical Centre (AMC) (Netherlands)
入组人数
280
状态
已完成
最后更新
11年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2007年3月5日
结束日期
待定
最后更新
11年前
研究类型
Interventional

研究者

发起方
Academic Medical Centre (AMC) (Netherlands)

入排标准

入选标准

  • Consecutive patients with an acute ST\-segment elevation MI undergoing primary PCI:
  • 1\. Primary PCI within six hours after onset of symptoms of myocardial infarction
  • 2\. Electrocardiographic evidence of persistent ST\-segment elevation of at least 0\.1 mV in two or more contiguous leads at the time of randomisation
  • 3\. Proximal obstruction of infarct related coronary artery with TIMI zero to two flow with minimal diameter of 2\.5 mm or more
  • 4\. The obstruction is amenable to the use of the PROXIS™ as judged by an experienced operator

排除标准

  • 1\. Younger than 18 years of age
  • 2\. Use of a thrombolytic agent within the previous 48 hours
  • 3\. Prior coronary artery bypass graft (CABG)
  • 4\. Contraindications to the use of a glycoprotein (GP) IIb/IIIa inhibitor
  • 5\. Co\-existent condition associated with a limited life expectancy

结局指标

主要结局

未指定

相似试验

进行中(未招募)
1 期
Acute Myocardial infarction Upbound to percutaneous coronary intervention, immediately (STEMI) or in the Next three Days (NSTEMI), and randomized to Subcutaneous Evolocumab or Normal strategies to reach guidelines LDL objectives in the real-world- The AMUNDSEN-real study
EUCTR2021-000573-80-FRAPHP DRCI
已完成
不适用
Cerebral Protection of Acute Embolic Burden During Transcatheter Aortic Valve Implantation * A Randomized Diffusion-Weighted MRI Study (CP-11134)severe headachedizzinessdifficulty in walkingloss of balance and coordinationblurred or double vision.Stroke: inability to move one or more limbs on one side of the bodyinability to understand or formulate speechinability to see one side of the visual fieldsudden10046973
NL-OMON42354Claret Medical, Inc.24
进行中(未招募)
不适用
PROTECT - Prophylaxis of ThromboEmbolism in Critical Care Trial - PROTECTCritically ill patients who require admission to the intensive care unit and need pharmacologic thromboprophylaxis
EUCTR2009-012387-13-GBMcMaster University3,650
进行中(未招募)
1 期
EMPIRE-Elafin Myocardial Protection from Ischaemia RepErfusion injury - Effect of elafin on myocardial injuryMyocardial ischaemia reperfusion injury Post-operative inflammation Post-ischaemic inflammatory injury
EUCTR2010-019527-58-GBHS Lothian80
已完成
不适用
Preventive Angioplasty in Myocardial Infarction TrialCoronary artery diseaseCirculatory SystemChronic ischaemic heart disease
ISRCTN73028481Queen Mary University of London (UK)600